Article
13 Nov 2025
FDA Considers Drug Pricing: Leadership Cites Consumer Cost As A Driver For Changes To Biosimilar Recommendations
RANKINGS
This author falls within the Top 20% for their listed topics and industry categories. Based on Mondaq users readership, this author is ranked as VERY POPULAR in United States
AUTHORS CONTENT
Article
30 Oct 2025
ATA EDGE 2025 Policy Conference
Article
13 Aug 2025
FDA Calls For Stronger Industry Collaboration On Infant And Child Food Recalls
Article
25 Oct 2024
GLP-1 Drugs: FDA Sued Over Removing Tirzepatide From The Drug Shortage List
Article
26 Sep 2024
Artificial Intelligence In Health Care: Key Considerations For Oncology
Article
19 Mar 2024
My Healthy Food Product Is Ready To Go To Market – What About Its Packaging?
Article
22 Feb 2024
Primer On Navigating VC For Growth In The Healthy F&B (Food & Beverage) Space
Article
09 Feb 2024
Bringing A New Healthy Food Ingredient To Market: Understanding The Regulatory Pathways
Article
01 Dec 2023
Who Regulates My Product?